COMPANY BLOG

CURE Pharmaceutical to Present on the Increased Bioavailability for Cannabinoids Due to New Delivery Technologies at O’Cannabiz Conference

GlobeNewswire•June 5, 2018 LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that CEO Rob Davidson will be presenting at the O’Cannabiz Conference & Expo on June 9 at 2:50 PM ET in Toronto, Canada. Davidson will discuss “Maximizing and Understanding the Benefits of…

Details

June 5, 2018Blog, Company News, News, twitter

CURE Pharmaceutical to Showcase Company Growth at the 8th LD Micro Invitational

LOS ANGELES, May 23, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 8th annual LD Micro Invitational on Monday, June 4th at 4 PM PT/ 7 PM ET at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. CEO Rob…

Details

May 23, 2018Blog, Company News, News

Wealth Closes Oversubscribed Non-Brokered Private Placement

VANCOUVER, British Columbia, May 23, 2018 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) (WML.V) (WMLLF) (SSE:WMLCL) (Frankfurt:EJZ) announces it has closed an oversubscribed non-brokered private placement previously announced on May 7, 2018 (the “Placement”). A total of 5,678,236 units (the “Units”) were issued under the Placement at a price of $1.10 per…

Details

May 23, 2018Blog, Company News, News, twitter

Wealth Announces Trinity Project Drill Program

May 07, 2018 08:00 ET | Source: Wealth Minerals Ltd VANCOUVER, British Columbia, May 07, 2018 (GLOBE NEWSWIRE) –– Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV:WML) (OTCQB:WMLLF) (SSE:WMLCL) (Frankfurt:EJZN), provides a Trinity Project (the “Project”) update. The Company is finalizing a drill contract and expects to begin drilling before the end of…

Details

May 7, 2018Blog, Company News, News, twitter

Energy Fuels Announces Q1-2018 Results

Denver, Colorado – May 3, 2018 Energy Fuels Inc. (NYSE MKT:UUUU; TSX:EFR) (“Energy Fuels” or the “Company”), today reported its financial results for the quarter ended March 31, 2018. The Company’s quarterly report on Form 10-Q has been filed with the U.S. Securities and Exchange Commission (“SEC”), and may be viewed on the Electronic Document…

Details

May 4, 2018Blog, Company News, News, twitter

Energy Fuels Closes Sale of Non-Core Uranium Properties in Wyoming; Adds $5.39 Million to Balance Sheet

Denver, Colorado – May 3, 2018 Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), a leading uranium producer in the U.S., is pleased to announce that it has closed the sale of certain non-core uranium properties in Wyoming to Uranium Energy Corp. (“UEC”) for $5.39 million, including $2.94 million of…

Details

May 3, 2018Blog, Company News, News, twitter

CURE Pharmaceutical Attracts Strategic Investment to Speed Its Cannabinoid Drug Delivery Production

GlobeNewswire May 1, 2018 OXNARD, Calif., May 01, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced it received an investment of $500,000 from a strategic partner to advance its cannabinoid-based drug delivery product line. This investment comes from a pharmaceutical partner in the form of a convertible…

Details

May 1, 2018Blog, Company News, News, twitter

CURE Pharmaceutical Reports Strong Progress and Sets Growth Roadmap for Remainder of Year

GlobeNewswire•April 03, 2018 OXNARD, Calif., April 03, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery company, today reported the company’s Q1 2018 accomplishments. The company strengthened its leadership team with biopharmaceutical expertise, secured additional financing, and boosted nutraceutical product distribution, while advancing towards the launch of its first pharmaceutical CUREfilm™ product. “We…

Details

April 3, 2018Blog, Company News, News, twitter